KMID : 1034820210170010059
|
|
Molecular & Cellular Toxicology 2021 Volume.17 No. 1 p.59 ~ p.67
|
|
N-type Cav channel inhibition by spider venom peptide of Argiope bruennichi
|
|
Hwang In-Wook
Shin Min-Kyoung Lee Yoo-Jung Kim Seung-Tae Lee Sue-Yeon Lee Byung-Jo Jang Won-Hee Yeo Joo-Hong Lee Seung-Ki Sung Jung-Suk
|
|
Abstract
|
|
|
Background: The spider venom is composed of various bioactive peptides and has well-known physiological characteristics, such as cytolytic and neurotoxic activities. However, there have been few studies on neurotoxic peptides derived from domestic indigenous spiders in Korea.
Objective: The study aimed to characterize and identify the venom peptide through genomic analysis from the domestic indigenous spider, Argiope bruennichi. Toxin-like peptides were selected using homology analysis against well-known toxin peptides along with the secondary structural characterization analysis by cysteine pattern and disulfide bonds. Modulation of voltage-gated calcium (Cav) channel was measured by Ca2+ influx using fluorescence dye.
Results: We found that a novel peptide Aranetoxin-Ab1a significantly reduced intracellular Ca2+ levels in human neuroblastoma cell line SH-SY5Y via the inactivation of N-type Cav channels. Decreased intracellular Ca2+ influx by the treatment of the peptide inactivated the extracellular-regulated protein kinase 1/2 and cAMP-response factor binding protein pathway.
Conclusion: Our results provide beneficial information for the potential development of drugs utilizing novel peptide derived from spider venom, showing the inhibition of N-type Cav by the peptide.
|
|
KEYWORD
|
|
Spider venom, Argiope bruennichi, Transcriptomics, RNA-sequencing, In silico analysis, Neurotoxicity
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|